# Clarification Brief: Germany Rating and Denmark Volume

> **Document type:** Analyst clarification request — agentic AI researcher prompt  
> **Author:** Weiche Lin  
> **Date:** 2026-04-26  
> **Follows from:** [`2026-04-gap-resolution-france-assessment.md`](./2026-04-gap-resolution-france-assessment.md)  
> **Status:** Open — two tasks, deliver one document

---

## Context for the Researcher

You are continuing work on an EU procurement data accessibility research project. The goal is to identify which EU member states have procurement infrastructure where tender specification documents (Layer 2) are publicly accessible and retrievable programmatically — without login-gating or platform fragmentation.

The research so far has produced the following confirmed verdicts:

| Country | Verdict |
|---|---|
| Estonia | Viable — proceed |
| Netherlands | Viable |
| Denmark | Viable — conditional on confirming healthcare IT volume |
| France | Ruled out |
| Italy | Ruled out |

Two items from the most recent research output (`2026-04-gap-resolution-france-assessment.md`) are unresolved and are blocking the final market selection decision. You have two tasks.

---

## Task 1 — Germany: Resolve or Remove the Summary Table Entry

### What happened

Your most recent summary table includes this row:

| Country | Layer 1 | Layer 2 | Verdict |
|---|---|---|---|
| Germany | ✅ TED + DTVP/Vergabe24 | ⚠️ Mixed — some open, some gated | **Conditional** |

Germany was explicitly excluded from the original research brief (`2026-04-country-research-brief.md`) on the basis that it has no single mandatory national procurement portal and that its procurement market is distributed across DTVP, Vergabe24, evergabe.de, Bund.de, and 16 Länder-level systems — the same structural fragmentation that ruled out Italy and France.

The "Conditional — Mixed (some open, some gated)" rating for Layer 2 is a significant upgrade from "Not Viable" and it appeared in the summary table without a supporting Germany section in the document, without any API tested, and without any document URLs verified.

### What is needed

You must do one of the following, and state clearly which you are doing and why:

**Option A — Evidence-backed claim.** If the "Conditional" rating is based on knowledge of specific German procurement portals where specification documents are publicly accessible without registration, provide that evidence now. For each portal cited:
- Name the portal and its URL
- Confirm whether it is publicly accessible without registration (test this, do not assume)
- Retrieve at least one specification document URL that works without authentication
- State which buyer types and Länder are covered by this portal
- Assess whether the covered scope is large enough to constitute a viable market segment on its own

**Option B — Remove the row.** If the "Conditional" rating cannot be supported with specific tested evidence, remove it from the summary table and state that Germany remains ruled out on the same fragmentation grounds documented in the original research brief.

Do not leave the row in the table without resolving it. An unvalidated "Conditional" rating on a market the size of Germany is misleading to the decision-maker.

### Acceptance criteria for Task 1

- [ ] Either: at least one German portal is tested with a specific document URL retrieved without authentication, a scope statement, and a revised verdict with supporting evidence
- [ ] Or: the Germany row is explicitly removed with a one-sentence explanation
- [ ] No unvalidated ratings remain in the summary table

---

## Task 2 — Denmark: Confirm Healthcare IT Tender Volume

### What happened

Your previous research confirmed that Denmark's Layer 2 documents are accessible via the `api.udbud.dk` URL pattern without authentication. The verdict was upgraded to "Viable — conditional on confirming healthcare IT tender volume."

The volume count was not provided. The condition has not been met.

### What is needed

Query the `udbud.dk` API or portal for the count of healthcare IT tenders published in 2023 and 2024. Use the following CPV scope, which matches the scope used across all other country assessments:

| CPV division | Category |
|---|---|
| `72xxxxxxx` | IT services |
| `48xxxxxxx` | Software packages and information systems |
| `85xxxxxxx` | Health and social work services |
| `33xxxxxxx` | Medical equipment and supplies |

**API entry point:** `https://api.udbud.dk/udbud` (public, no authentication required)

Provide:
- The count of above-threshold notices in each CPV division for 2023 and 2024 separately
- Total combined count across all four divisions for each year
- 2–3 example notices from the healthcare IT subset (buyer name, CPV code, estimated value, notice URL) to confirm the corpus is relevant, not just large

**Threshold for viability:** A combined annual count of 50 or more relevant healthcare IT notices is sufficient to support a v1 market. Below 30 is insufficient. Between 30 and 50 is borderline and should be flagged with a recommendation.

### Acceptance criteria for Task 2

- [ ] CPV-filtered notice counts provided for 2023 and 2024 separately
- [ ] Total annual count stated clearly
- [ ] A viability verdict given: Sufficient / Borderline / Insufficient
- [ ] 2–3 example notices cited to confirm relevance of the corpus

---

## Deliverable Format

Return a single document that resolves both tasks. Use the following structure exactly:

```
# Germany and Denmark Clarification: Research Response

## Task 1 — Germany

[Option A or Option B — state which and why]

[Evidence or removal statement]

## Task 2 — Denmark Healthcare IT Volume

Denmark — CPV-filtered notice counts

| CPV division | 2023 count | 2024 count |
|---|---|---|
| 72xxxxxxx (IT services) | | |
| 48xxxxxxx (Software) | | |
| 85xxxxxxx (Health services) | | |
| 33xxxxxxx (Medical equipment) | | |
| **Total** | | |

Example notices: [3 examples with buyer, CPV, value, URL]

Volume verdict: [Sufficient / Borderline / Insufficient]
Recommendation: [1–2 sentences]

## Updated Country Viability Summary

[Reproduce the full summary table with Germany either evidence-backed or removed, and Denmark's verdict updated to reflect the volume finding]
```

---

## Research Boundaries

- Do not re-investigate Estonia, the Netherlands, France, or Italy — those verdicts are final.
- Do not expand scope to other countries not already in the research trail.
- Do not speculate. If a portal requires testing and you cannot test it, say so explicitly rather than rating it based on documentation alone.

---

*Brief issued 2026-04-26. Responds to gaps identified in [`2026-04-assessment-review-and-next-steps.md`](./2026-04-assessment-review-and-next-steps.md).*
